News Analysis Unlike other vaccines, influenza shots are administered yearly, yet offer generally lower protection than most routinely recommended vaccines, from as low as 10 percent to as high as 60 percent. This season’s flu jab was only 16 percent effective, according to the Centers for Disease Control and Prevention (CDC). Scientists had hoped to…
Pharmaceutical Companies Expanding mRNA Technology to Treat Influenza
US FDA Schedules Meeting on Additional COVID-19 Vaccine Boosters
U.S. regulators plan to consult a panel of expert advisers on April 6 on whether additional COVID-19 vaccine boosters are necessary. The Vaccines and Related Biological Products Advisory Committee will convene for a virtual meeting “to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for…
FDA Schedules Meeting on Additional COVID-19 Vaccine Booster Shots
U.S. regulators plan to consult a panel of expert advisers on April 6 on whether additional COVID-19 vaccine booster doses are necessary. The Vaccines and Related Biological Products Advisory Committee will convene for a virtual meeting “to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus…
FDA Schedules Meeting on Additional COVID-19 Vaccine Boosters
U.S. regulators plan to consult a panel of expert advisers on April 6 on whether additional COVID-19 vaccine booster doses are necessary. The Vaccines and Related Biological Products Advisory Committee will convene for a virtual meeting “to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus…
AstraZeneca COVID Drug Performs Well Against Omicron Subvariants: Study
A COVID-19 drug made by AstraZeneca did nearly as well against subvariants of the Omicron virus variant as the main variant, according to a new study. Researchers with AstraZeneca, the Washington University School of Medicine, and other institutions used mice to test the monoclonal antibody combination, known as Evusheld, and a drug made by Vir Biotechnology,…
10 Doctor-Recommended Ways to Improve Your Overall Health
While investing in your health and wellness can sound like an overwhelming goal, doctors say that there are easy, tangible steps you can take to feel your best and better protect your health. “It is always the right time to consider your personal goals, and how you can make positive health choices,” says American Medical…
Woman Died of Rare Brain Bleed After Getting COVID-19 Vaccine: Coroner
A coroner in the United Kingdom determined that a woman died from a side-effect caused by the AstraZeneca COVID-19 vaccine. The woman was identified as 34-year-old Kim Lockwood, who had complained of experiencing a headache eight days after taking the shot in March of 2021, said the South Yorkshire Coroner Nicola Mundy in a statement to the…
FDA to Consult Advisory Panel About Additional COVID-19 Vaccine Boosters
The U.S. Food and Drug Administration (FDA) plans to consult a panel of experts before clearing additional COVID-19 vaccine booster shots. The current plan is “to gather our independent panel of outside experts next month to have a transparent discussion about considerations for 2022 booster shots, including whether and when those boosters may be needed…
‘Low-Value’ Medical Tests and Procedures
March 20, 2022
admin
American Heart AssociationBrighthealthHealth ConditionsHealth NewsHeart Healthmedical tests and proceduresNews & DiscoveriesUncategorized
0 Comment
At what point does the best quality care lose its value? That’s a question a new report by the American Heart Association (AHA) has attempted to answer. These days, there are several diagnostic tests and procedures that can offer plenty of information to both patients and doctors. But are they worth it? Just because humans…
Experimental COVID-19 Treatment Performed Well in Clinical Trial
An experimental treatment greatly reduced the risk of hospitalization and emergency room visits in people who contracted COVID-19, according to the maker of the drug and investigators running a clinical trial. California-based Eiger BioPharmaceuticals and investigators running the TOGETHER trial say (pdf) that the treatment, Peginterferon Lambda, cut the risk of needing hospital care by 50…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`